Vanguard Global Advisers
EVH icon

Vanguard Global Advisers’s Evolent Health EVH Stock Holding History

Vanguard Global Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
264,477
+163,930
+163% +$629K ﹤0.01% 1507
2026
Q1 		$229K Buy
+100,547
New +$319K ﹤0.01% 2370

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vanguard Global Advisers's EVH Position: Q2 2026 in Review

Vanguard Global Advisers increased its Evolent Health (EVH) stake by 163% in Q2 2026, buying an estimated $629K and bringing the position to 264,477 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Vanguard Global Advisers first reported a position in EVH in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Vanguard Global Advisers held 264,477 shares of Evolent Health worth $1.43M as of Q2 2026.
  • Vanguard Global Advisers bought 163,930 Evolent Health shares in Q2 2026, an estimated $629K.
  • Evolent Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1507 holding.
  • Vanguard Global Advisers first reported a position in Evolent Health in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.